BYSI

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

BeyondSpring Inc

NASDAQ | BYSI

1.90

USD

$0.00

(

0.00%

)

At Close (As of Dec 3, 2025)

$83.09M

Market Cap

-

P/E Ratio

-0.2

EPS

$3.44

52 Week High

$0.98

52 Week Low

HEALTHCARE

Sector

BYSI Chart

Recent Chart
Price Action

BYSI Technicals

Tags:

BYSI Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$285K
Total Revenue $0
Cost Of Revenue $285K
Costof Goods And Services Sold $285K
Operating Income -$8.8M
Selling General And Administrative $6.1M
Research And Development $2.6M
Operating Expenses $8.8M
Investment Income Net -
Net Interest Income $59K
Interest Income $59K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $285K
Income Before Tax -$8.8M
Income Tax Expense $96K
Interest And Debt Expense -
Net Income From Continuing Operations -$8.9M
Comprehensive Income Net Of Tax -
Ebit -$8.8M
Ebitda -$8.5M
Net Income -$11M

Revenue & Profitability

Earnings Performance

BYSI Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $34M
Total Current Assets $29M
Cash And Cash Equivalents At Carrying Value $2.9M
Cash And Short Term Investments $2.9M
Inventory -
Current Net Receivables -
Total Non Current Assets $5.7M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $26M
Other Non Current Assets -
Total Liabilities $49M
Total Current Liabilities $11M
Current Accounts Payable $295K
Deferred Revenue -
Current Debt -
Short Term Debt $282K
Total Non Current Liabilities $38M
Capital Lease Obligations $589K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $589K
Other Current Liabilities -$17M
Other Non Current Liabilities -
Total Shareholder Equity -$33M
Treasury Stock -
Retained Earnings -$407M
Common Stock $4K
Common Stock Shares Outstanding $40M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$16M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $285K
Capital Expenditures $224K
Change In Receivables -
Change In Inventory -$19K
Profit Loss -
Cashflow From Investment -$12M
Cashflow From Financing $27M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$11M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$285K
Total Revenue $0
Cost Of Revenue $285K
Costof Goods And Services Sold $285K
Operating Income -$8.8M
Selling General And Administrative $6.1M
Research And Development $2.6M
Operating Expenses $8.8M
Investment Income Net -
Net Interest Income $59K
Interest Income $59K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $285K
Income Before Tax -$8.8M
Income Tax Expense $96K
Interest And Debt Expense -
Net Income From Continuing Operations -$8.9M
Comprehensive Income Net Of Tax -
Ebit -$8.8M
Ebitda -$8.5M
Net Income -$11M

BYSI News

BYSI Profile

BeyondSpring Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

BeyondSpring Inc. is a leading clinical-stage biopharmaceutical company based in New York, dedicated to advancing innovative immuno-oncology therapies to address unmet medical needs in cancer treatment. With a robust pipeline that includes its lead candidate, which has shown promising results in clinical trials, BeyondSpring aims to enhance the efficacy and safety of cancer care. By leveraging cutting-edge scientific research and strong partnerships, the company is positioned to make significant contributions to the field of oncology and deliver transformative therapies to patients worldwide.

LPTX
+368.57%
$2.05
PAVS
-29.35%
$0.05
IXHL
+12.68%
$0.44
INTC
+8.64%
$43.47
NVDA
-1.03%
$179.59
KITT
+115.88%
$1.56
PLRZ
+131.96%
$7.33
VHAI
0.00%
$0.00
PLUG
+9.89%
$2.11
TWOH
0.00%
$0.00
NIO
-4.97%
$4.78
ONDS
+6.46%
$8.07
TSLA
+4.07%
$446.74
IPG
-1.95%
$24.57
ASST
+1.44%
$1.05
BYND
-3.10%
$1.25
BITF
+0.32%
$3.11
VALE
+3.25%
$13.31
AXDX
-61.36%
$0.03
AAL
+2.24%
$14.56
IREN
+6.90%
$43.96
BMNR
+5.20%
$33.57
PFE
+1.84%
$25.61
NFLX
-4.92%
$103.96
SOFI
-1.49%
$29.07
ADAP
-15.14%
$0.05
BBD
-2.49%
$3.57
MRVL
+7.15%
$99.54
DNN
+2.77%
$2.59
F
+1.11%
$13.10
INHD
-6.65%
$0.13
AAPL
-0.71%
$284.15
SOND
-23.45%
$0.12
AMD
-2.05%
$215.24
BMNU
+9.94%
$8.07
MARA
+4.70%
$12.47
ACHR
+8.43%
$8.29
CAN
+2.04%
$0.96
GOOGL
+1.20%
$319.63
RMBL
+60.50%
$3.21
QBTS
+11.37%
$25.06
LNW
-3.71%
$86.22
ABEV
+0.38%
$2.58
ADD
-25.47%
$0.05
BAC
+1.67%
$54.08
BTBT
+4.01%
$2.33
AMZN
-0.87%
$232.38
SRM
+53.27%
$10.30
RIVN
+0.40%
$17.23
GRAB
+0.19%
$5.27
MSFT
-2.50%
$477.73
GOOG
+1.45%
$320.62
PCG
-0.58%
$15.23
CIFR
+5.61%
$18.63
KVUE
-2.09%
$16.86
CLSK
+5.30%
$14.43
T
-1.04%
$25.52
PLTR
+3.15%
$176.08
WULF
+1.47%
$14.43
HBAN
+0.12%
$16.56
WLGS
-5.57%
$0.04
PLTD
-3.30%
$6.73
SNAP
-0.26%
$7.62
MTSR
-0.35%
$70.50
RGTI
+9.08%
$26.05
RIG
-0.91%
$4.31
BMY
+5.66%
$50.98
MSTR
+3.89%
$188.39
BTG
+1.24%
$4.48
HOOD
+6.10%
$133.64
WMT
+1.81%
$114.45
CHR
-6.96%
$0.04
ASBP
-10.81%
$0.08
VICI
-0.48%
$28.45
AFMD
-34.94%
$0.18
NOK
+1.05%
$6.25
MCHP
+12.16%
$63.61
WBD
+0.16%
$24.57
IMRN
-10.91%
$1.55
CMG
-0.55%
$33.95
AVGO
-1.16%
$381.57
SOUN
-2.60%
$11.22
GTLB
-12.77%
$37.83
CMND
-14.27%
$0.11
ITUB
+0.38%
$7.92
M
-1.10%
$22.46
PMAX
+26.43%
$2.87
PSTG
-27.29%
$68.87
CRCL
+11.53%
$86.37
APLD
+4.67%
$29.36
CGC
+4.50%
$1.16
AMCR
+0.77%
$8.46
YGMZ
-12.29%
$0.07
KO
-1.77%
$70.67
VZ
+0.22%
$40.70
CRWV
+4.37%
$79.36
RXRX
+7.87%
$4.66
SMR
+4.59%
$18.91
GRYP
-10.38%
$1.38
VIVK
-13.89%
$0.09
LPTX
+368.57%
$2.05
PAVS
-29.35%
$0.05
IXHL
+12.68%
$0.44
INTC
+8.64%
$43.47
NVDA
-1.03%
$179.59
KITT
+115.88%
$1.56
PLRZ
+131.96%
$7.33
VHAI
0.00%
$0.00
PLUG
+9.89%
$2.11
TWOH
0.00%
$0.00
NIO
-4.97%
$4.78
ONDS
+6.46%
$8.07
TSLA
+4.07%
$446.74
IPG
-1.95%
$24.57
ASST
+1.44%
$1.05
BYND
-3.10%
$1.25
BITF
+0.32%
$3.11
VALE
+3.25%
$13.31
AXDX
-61.36%
$0.03
AAL
+2.24%
$14.56
IREN
+6.90%
$43.96
BMNR
+5.20%
$33.57
PFE
+1.84%
$25.61
NFLX
-4.92%
$103.96
SOFI
-1.49%
$29.07
ADAP
-15.14%
$0.05
BBD
-2.49%
$3.57
MRVL
+7.15%
$99.54
DNN
+2.77%
$2.59
F
+1.11%
$13.10
INHD
-6.65%
$0.13
AAPL
-0.71%
$284.15
SOND
-23.45%
$0.12
AMD
-2.05%
$215.24
BMNU
+9.94%
$8.07
MARA
+4.70%
$12.47
ACHR
+8.43%
$8.29
CAN
+2.04%
$0.96
GOOGL
+1.20%
$319.63
RMBL
+60.50%
$3.21
QBTS
+11.37%
$25.06
LNW
-3.71%
$86.22
ABEV
+0.38%
$2.58
ADD
-25.47%
$0.05
BAC
+1.67%
$54.08
BTBT
+4.01%
$2.33
AMZN
-0.87%
$232.38
SRM
+53.27%
$10.30
RIVN
+0.40%
$17.23
GRAB
+0.19%
$5.27
MSFT
-2.50%
$477.73
GOOG
+1.45%
$320.62
PCG
-0.58%
$15.23
CIFR
+5.61%
$18.63
KVUE
-2.09%
$16.86
CLSK
+5.30%
$14.43
T
-1.04%
$25.52
PLTR
+3.15%
$176.08
WULF
+1.47%
$14.43
HBAN
+0.12%
$16.56
WLGS
-5.57%
$0.04
PLTD
-3.30%
$6.73
SNAP
-0.26%
$7.62
MTSR
-0.35%
$70.50
RGTI
+9.08%
$26.05
RIG
-0.91%
$4.31
BMY
+5.66%
$50.98
MSTR
+3.89%
$188.39
BTG
+1.24%
$4.48
HOOD
+6.10%
$133.64
WMT
+1.81%
$114.45
CHR
-6.96%
$0.04
ASBP
-10.81%
$0.08
VICI
-0.48%
$28.45
AFMD
-34.94%
$0.18
NOK
+1.05%
$6.25
MCHP
+12.16%
$63.61
WBD
+0.16%
$24.57
IMRN
-10.91%
$1.55
CMG
-0.55%
$33.95
AVGO
-1.16%
$381.57
SOUN
-2.60%
$11.22
GTLB
-12.77%
$37.83
CMND
-14.27%
$0.11
ITUB
+0.38%
$7.92
M
-1.10%
$22.46
PMAX
+26.43%
$2.87
PSTG
-27.29%
$68.87
CRCL
+11.53%
$86.37
APLD
+4.67%
$29.36
CGC
+4.50%
$1.16
AMCR
+0.77%
$8.46
YGMZ
-12.29%
$0.07
KO
-1.77%
$70.67
VZ
+0.22%
$40.70
CRWV
+4.37%
$79.36
RXRX
+7.87%
$4.66
SMR
+4.59%
$18.91
GRYP
-10.38%
$1.38
VIVK
-13.89%
$0.09
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.